Newsroom

Recent News Releases

November 24, 2020 11/24/2020

Announcement of Making Nihon Pharmaceutical Co., Ltd. a Wholly-owned Subsidiary Through Simple Share Exchange

November 13, 2020 11/13/2020

Final Results from the Phase 3 HELP Study^™ Open-Label Extension Support TAKHZYRO^®(lanadelumab-flyo) Injection as a Long-term Preventive Treatment Option in Patients with Hereditary Angioedema

November 5, 2020 11/5/2020

Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting

October 29, 2020 10/29/2020

Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with Moderna and Government of Japan

October 29, 2020 10/29/2020

Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Understanding the Role of Orexin in Sleep and Wakefulness

Learn more

Exploring New Paths in Narcolepsy

Learn more

Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce

Learn more

Guided by Our Values: Supporting Global COVID-19 Response

Learn more

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.